Movement Disorders in Psychiatry examines the complex interface between movement disorders and psychiatry, addressing both specific movement disorders in psychiatry and behavioral syndromes associated with diseases categorized as movement disorders. This volume provides an overview of clinical definitions and pathophysiology of movement disorders and reviews specific movement disorders associated with drugs of abuse and psychotropic medications, including tardive dyskinesia, akathisia, and neuroleptic malignant syndrome. Further chapters discuss movement disorders seen in primary psychiatric disorders, such as autism and schizophrenia, as well as diseases with concurrent movement disorder and behavioral symptoms, such as Huntington's disease, Parkinson's disease, frontotemporal dementia, Tourette's syndrome, and autoimmune conditions. Movement Disorders in Psychiatry offers an in-depth perspective on movement disorders with treatment and practical management strategies for related challenges in clinical practice. Table of Contents: Preface Part I: Movement Disorders Overview Chapter 1: Introduction to the Movement Disorders: Definition and Clinical Phenotypes
Erin Furr-Stimming and William G. Ondo Chapter 2: Pathophysiology of Primary and Secondary Movement Disorders
Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira Zonzini, Daniel R. Benke, and José Augusto Pochapski Part II: Movement Disorders Associated with Psychotropics Chapter 3: Dopamine Antagonist-Induced Parkinsonism
Abdulmunaim M. Eid and William G. Ondo Chapter 4: Akathisia
Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L. Teixeira Chapter 5: Tardive Dyskinesia
Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L. Teixeira Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome
Haitham Salem, Brittany Finocchio, and Teresa Pigott Chapter 7: Movement Disorders Associated with SSRIs
Jennifer G. Goldman and Carlos Manuel Guerra Galicia Chapter 8: The Under Recognized Movement Disorders Associated with Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine
Melody Badii and William G. Ondo Chapter 9: Movement Disorders Associated with Stimulants and Other Drugs of Abuse
Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario Manto Part III: Movement Disorders Seen in Primary Psychiatric Disorders Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum Disorders
Johannes Schröder and Christina J. Herold Chapter 11: Stereotypies in Childhood Developmental Disorders and Neurodegenerative Diseases
Joohi Jimenez-Shahed Chapter 12: Catatonia and Hypokinetic Movement Disorders
Nidaullah Mian, Carla Bejjani, and Raja Mehanna Chapter 13: Functional Movement Disorders
Jennifer S. Sharma and Alberto J. Espay Part IV: Diseases with Concurrent Psychiatric and Movement Disorders Symptoms Chapter 14: Tics and Tourette Syndrome
Abhishek Lenka and Joseph Jankovic Chapter 15: Huntington's Disease
Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin Furr-Stimming Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic Causes of Chorea
Ricardo Maciel, Débora Palma Maia, and Francisco Cardoso Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes
Julia Ridgeway-Diaz and Laura Marsh Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing Features, Genetics, Pathology, and Associated Movement Disorders
Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz Chapter 19: Restless Legs Syndrome and Psychiatric Issues
Emmanuel H. During and John W. Winkelman Chapter 20: Neurometabolic Diseases
Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig Chapter 21: Autoimmune and Paraneoplastic Encephalopathies
James F. Rini, Bradley T. Peet, and Michael D. Geschwind
About the Editors:
Antonio L. Teixeira, MD, PhD, MSc, is Professor of Psychiatry and Neurology at University of Texas Health Houston where he leads the Neuropsychiatry Program. Dr. Teixeira is involved in research and clinical care of behavioral disorders in patients with Huntington's disease, Parkinson's disease, and other neurodegenerative diseases. Erin Furr Stimming, MD, is Professor of Neurology and founding Director of the Huntington's Disease Society of America Center of Excellence at University of Texas Health Houston. Dr. Furr Stimming is Fellow of the American Academy of Neurology and Director of the Neurology clerkship at McGovern Medical School. She devotes her time to clinical care and research for individuals with Huntington's disease, Parkinson's disease, and other movement disorders in addition to educating future physicians. William G. Ondo, MD, is Director of the Movement Disorder Clinic at Houston Methodist Hospital and Professor of Neurology at Weill Cornell Medical School and Texas A&M. Dr. Ondo has served as primary, treating, and sub-investigator for many research projects involving adult and pediatric movement disorder research. Contributors: Albert Y. Amran
Karen Anderson
Melody Badii
Carla Bejjani
Daniel R. Benke
Moira Black
Avram S. Bukhbinder
Francisco Cardoso
Claudio Da Cunha
Emmanuel H. During
Abdulmunaim M. Eid
Alberto J. Espay
Brittany Finocchio
Erin Furr-Stimming
Carlos Manuel Guerra Galicia
Jordi Gandini
Michael D. Geschwind
Jennifer G. Goldman
Christina J. Herold
Joseph Jankovic
Joohi Jimenez-Shahed
Mary Kay Koenig
Abhishek Lenka
Andy Liu
Ricardo Maciel
Débora Palma Maia
Mario Manto
Laura Marsh
Raja Mehanna
Nidaullah Mian
Satyajit Mohite
William G. Ondo
Ossama T. Osman
Vinicius Sousa Pietra Pedroso
Bradley T. Peet
Teresa Pigott
José Augusto Pochapski
Julia Ridgeway-Diaz
James F. Rini
Natalia Pessoa Rocha
Sam Nicholas Russo
Haitham Salem
João Vinícius Salgado
William Sánchez-Luna
Johannes Schröder
Paul E. Schulz
Lokesh Shahani
Jennifer S. Sharma
Antonio L. Teixeira
Nivedita Thakur
Luiz Paulo Vasconcelos
John W. Winkelman
Fernando Henrique Teixeira Zonzini
| 
